Índice Bovespa

US Dollar vs BRL

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

DYN Dyne Therapeutics Inc

29,69

-0,04 (-0,13%)

22 Nov 2024 - Fechado

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Carlo Incerti

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Dyne Therapeutics (NASDAQ:DYN)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024

Click aqui para mais gráficos Dyne Therapeutics.

Dyne Therapeutics (NASDAQ:DYN)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024

Click aqui para mais gráficos Dyne Therapeutics.

Notícias Dyne Therapeutics Inc

Form 144 - Report of proposed sale of securities
Sexta, 22 de Novembro de 2024 (2 dias atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 18 de Novembro de 2024 (6 dias atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 18 de Novembro de 2024 (6 dias atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 18 de Novembro de 2024 (6 dias atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 18 de Novembro de 2024 (6 dias atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 18 de Novembro de 2024 (6 dias atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 18 de Novembro de 2024 (6 dias atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Sexta, 15 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Quinta, 14 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quinta, 14 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quinta, 14 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Terça, 12 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Mais Notícias de Dyne Therapeutics Inc

Asia Carbon Industries (CE)

Amundi ShortDAX Daily -2...

Vontobel Financial Produ...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições